Literature DB >> 3914701

A double-blind comparative study of piroxicam and ibuprofen in the treatment of rheumatoid arthritis.

G E McLaughlin.   

Abstract

Recommended dosages of nonsteroidal anti-inflammatory drugs have increased considerably since their introduction. The maximum recommended dosage for ibuprofen, a widely prescribed drug for the treatment of rheumatoid arthritis, has increased from 400 mg three or four times a day (at the time of its introduction) to 2,400 mg per day at present. Piroxicam at 20 mg per day was compared with ibuprofen at 2,400 mg per day in 20 patients with rheumatoid arthritis. Both drugs were found to be effective, with similar side-effect profiles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3914701     DOI: 10.1016/0049-0172(85)90054-x

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  2 in total

1.  Piroxicam and doxepin--an alternative to narcotic analgesics in managing advanced cancer pain.

Authors:  M L Cohn; A F Machado; R Bier; M Cohn
Journal:  West J Med       Date:  1988-03

2.  DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug.

Authors:  Alfonso E Bello
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-10       Impact factor: 5.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.